This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Transient thickening of the macular retinal nerve fibre layer in acute optic neuritis

Transient thickening of the macular retinal nerve fibre layer in acute optic neuritis
Reviewed by Claire Howard

1 December 2022 | Claire Howard | EYE - Neuro-ophthalmology | Optic neuritis, axonal degeneration, neurofilament protein, retina, tissue
Share This

Acute optic neuritis (ON) causes axonal degeneration, which can be quantified from the blood by neurofilament protein (Nf) levels. Within about three months, atrophy of the retinal nerve fibre layer (RNFL) follows. However, it remains challenging to explain why there is also transient thickening of the macular RNFL in acute ON, not related to optic disc swelling, in some patients in the studies reviewed. The authors of this paper hypothesised that because of the association of axonal diameter with Nf concentration, this transient phenomenon could be related to a change of retinal tissue Nf levels. The concentration of retinal tissue Nf levels following ON is not known. This paper presents an experimental model to investigate this theory further. The myelin-oligodendrocyte-glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE) model was used to investigate the retinas of Brown Norway rats with (i) visual evoked potentials (VEP) confirmed ON, (ii) VEP confirmed absence of ON and (iii) control animals. Twenty retinas were collected from MOG-EAE and control rats 27 days after immunisation. Retinal tissue Nf concentrations per total protein (μg/mg) were significantly higher in MOG-EAE rats with ON (median 4.29, interquartile range [IQR] 3.41-5.97) compared with MOG-EAE rats without ON (1.14, IQR 1.10-1.67) or control rats (0.93, IQR 0.45-4.00). The data suggest that up-regulation of Nf expression in the retinal ganglion cells precedes development of RNFL atrophy and plausibly explains the transient increase of axonal diameter and RNFL thickening. In conclusion, this paper presents a concept which helps to integrate structural and biomarker observations in ON. The proposed sequence of pathology in ON is that, following the inflammatory damage to optic nerve axons, retinal ganglion cells react in a compensatory way, which includes up-regulate expression of Nf proteins. This then leads to a transient increase of the axonal diameter explaining the OCT observation of RNFL thickening. This phase is followed by one of two options: preservation of axonal integrity with normalisation of the RNFL or progression of retrograde axonal degeneration with atrophy of the RNFL. During this latter phase, which lasts for about three months, the intraretinal up-regulation of Nf isoforms combined with anterograde axonal transport sustains the increase of Nf isoforms levels measured in the patients’ blood.

Upregulated retinal neurofilament expression in experimental optic neuritis.
Weissert R, Hugosson T, Petzold A.
NEURO-OPHTHALMOLOGY
2022;46(4):215-9.
Share This
CONTRIBUTOR
Claire Howard

Salford Royal NHS Foundation Trust, Salford, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency